Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity

Journal of Molecular Medicine

Volumn 86, Issue 2, 2008, Pages 197-209

  Cecchi, Cristina ^a   Pensalfini, Anna ^a   Stefani, Massimo ^a,c   Baglioni, Serena ^a   Fiorillo, Claudia ^a   Cappadona, Silvia ^a   Caporale, Roberto ^b   Nosi, Daniele ^a   Ruggiero, Marco ^a   Liguri, Gianfranco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Amyloid aggregates; Amyloid toxicity; Apoptosis; Cell cycle; Protein aggregation

Indexed keywords

AMYLOID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL MEMBRANE; CELL SYNCHRONIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PROTEIN AGGREGATION;

AMYLOID BETA-PROTEIN; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CHOLESTEROL; ENDOCYTOSIS; HUMANS; NERVE DEGENERATION; NEUROBLASTOMA; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHENOTYPE; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 38649118539     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0265-3     Document Type: Article

References (45)

1. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678-699
2. Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15:3-16
3. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489
4. Kourie JI, Henry CL (2002) Ion channel formation and membrane-linked pathologies of misfolded hydrophobic proteins: the role of dangerous unchaperoned molecules. Clin Exp Pharmacol Physiol 29:741-753
5. Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64:2660-2666
6. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain. Pathol 9:133-146
7. Mattson MP, Guo Q, Furukawa K, Pedersen WA (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 70:1-14
8. Cecchi C, Fiorillo C, Baglioni S, Pensalfini A, Bagnoli S, Nacmias B, Sorbi S, Nosi D, Relini A, Liguri G (2007) Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts. Neurobiol Aging 28:863-876
9. 1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156:519-529
10. Velez-Pardo C, Arroyave ST, Lopera F, Castano AD, Jimenez Del Rio M (2001) Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A mutation. J Alzheimer Dis 3:409-415
11. Datki Z, Juhasz A, Galfi M, Soos K, Papp R, Zadori D, Penke B (2003) Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res Bull 62:223-229
12. Olesen OF, Dago L, Mikkelsen JD (1998) Amyloid beta neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells. Brain Res Mol Brain Res 57:266-274
13. Copani A, Melchiorri D, Caricasole A, Martini F, Sale P, Carnevale R, Gradini R, Sortino MA, Lenti L, De Maria R, Nicoletti F (2002) Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J Neurosci 22:3963-3968
14. Frasca G, Chiechio S, Vancheri C, Nicoletti F, Copani A, Angela Sortino M (2004) Beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: correlation with the MAP kinase pathway. J Mol Neurosci 22:231-236
15. Yang Y, Mufson E, Herrup K (2003) Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer disease. J Neurosci 23:2557-2563
16. Khurana V, Feany MB (2007) Connecting cell-cycle activation to neurodegeneration in Drosophila. Biochim Biophys Acta 1772:446-456
17. Raina AK, Monteiro MJ, McShea A, Smith MA (1999) The role of cell cycle-mediated events in Alzheimer's disease. Int J Exp Pathol 80:71-76
18. Hussman JW, Nochlin D, Vincent I (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegenerative disease. Neurobiol Aging 21:815-828
19. Lie DC, Song H, Colamarino SA, Ming GL, Gage FH (2004) Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44:399-421
20. Kruman LI, Wersto RP, Cardozo-Pelaez F, Smilenov L, Chan SL, Chrest FJ, Emokpae R Jr, Gorospe M, Mattson MP (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549-561
21. Ritzel RA, Butler PC (2003) Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 52:1701-1708
22. Herrup K, Neve R, Ackerman SL, Copani A (2004) Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 24:9232-9239
23. Park DS, Levine B, Ferrari G, Greene LA (1997) Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci 17:8975-8983
24. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277:32046-32053
25. Lange Y, Ramos BV (1983) Analysis of the distribution of cholesterol in the intact cell. J Biol Chem 258:15130-15134
26. Datki Z, Papp R, Zadori D, Soos K, Fulop L, Juhasz A, Laskay G, Hetenyi C, Mihalik E, Zarandi M et al (2004) In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour. Neurobiol Dis 17:507-515
27. Cecchi C, Baglioni S, Fiorillo C, Pensalfini A, Liguri G, Nosi D, Rigacci S, Bucciantini M, Stefani M (2005) Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J Cell Sci 118:3459-3470
28. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
29. Arispe N, Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J 16:1526-1536
30. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1-15
31. Asnaghi L, Bruno P, Priulla M, Nicolin A (2004) mTOR: a protein kinase switching between life and death. Pharmacol Res 50:545-549
32. Cooper S (2004) Rejoinder: whole-culture synchronization cannot, and does not, synchronize cells. Trends Biotechnol 22:274-276
33. Spellman PT, Sherlock G (2004) Final words: cell age and cell cycle are unlinked. Trends Biotecnol 22:277-278
34. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WI (2004) Synaptic targeting by Alzheimer's-related amyloid β oligomers. J Neurosci 24:10191-10200
35. Shaked GM, Kummer MP, Lu DC, Galvan V, Bredesen DE, Koo EH (2006) Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J 20:1254-1256
36. Yip CM, Elton EA, Darabie AA, Morrison MR, McLaurin J (2001) Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J Mol Biol 311:723-734
37. Kakio A, Nishimoto S-L, Kozutsumi Y, Matsuzaki K (2003) Formation of membrane-active form of amyloid β-protein in raft-like model membranes. Biochim Biophys Res Commun 303:514-518
38. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, Dotti CG (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167:953-960
39. Kojro E, Gimp G, Lammrich S, März W, Fahrenholz F (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the a-secretase ADAM 10. Proc Natl Acad Sci USA 98:5815-5820
40. Benvenuti S, Saccardi R, Luciani P, Urbani S, Deledda C, Cellai I, Arancini F, Squecco R, Rosati F, Danza G, Gelmini S, Greeve I, Rossi M, Maggi R, Serio M, Peri A (2006) Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1. Exp Cell Res 312:2592-2604
41. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 20:7345-7352
42. Schwab BL, Guerini D, Didszun C, Bano D, Ferrando-May E, Fava E, Tam J, Xu D, Xanthoudakis S, Nicholson DW et al (2002) Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ 9:818-831
43. Squier TC (2001) Oxidative stress and protein aggregation during biological aging. Exp Gerontol 36:1539-1550
44. Lie DC, Song H, Colamarino SA, Ming GL, Gage FH (2004) Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44:399-421
45. Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 83:1509-1524